Details for New Drug Application (NDA): 202332
✉ Email this page to a colleague
The generic ingredient in OXYBUTYNIN CHLORIDE is oxybutynin chloride. There are sixteen drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the oxybutynin chloride profile page.
Summary for 202332
Tradename: | OXYBUTYNIN CHLORIDE |
Applicant: | Zydus Pharms |
Ingredient: | oxybutynin chloride |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 202332
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Suppliers and Packaging for NDA: 202332
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 202332 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8219 | 0615-8219-39 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8219-39) |
OXYBUTYNIN CHLORIDE | oxybutynin chloride | TABLET, EXTENDED RELEASE;ORAL | 202332 | ANDA | NCS HealthCare of KY, LLC dba Vangard Labs | 0615-8220 | 0615-8220-39 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (0615-8220-39) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 5MG | ||||
Approval Date: | Jun 26, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 10MG | ||||
Approval Date: | Jun 26, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET, EXTENDED RELEASE;ORAL | Strength | 15MG | ||||
Approval Date: | Jun 26, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription